IRIS
MAIDA, Ivana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 4.250
NA - Nord America 3.802
AS - Asia 2.756
SA - Sud America 2.344
AF - Africa 143
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 13
Totale 13.323
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.709
BR - Brasile 2.123
IT - Italia 1.572
CN - Cina 1.021
SG - Singapore 945
UA - Ucraina 938
FR - Francia 427
DE - Germania 413
HK - Hong Kong 352
SE - Svezia 259
FI - Finlandia 164
IE - Irlanda 97
GB - Regno Unito 80
AR - Argentina 74
RU - Federazione Russa 68
TR - Turchia 67
NL - Olanda 47
BD - Bangladesh 43
IQ - Iraq 42
CZ - Repubblica Ceca 40
ZA - Sudafrica 38
EC - Ecuador 36
KR - Corea 32
MA - Marocco 32
MX - Messico 32
PK - Pakistan 31
CA - Canada 28
UZ - Uzbekistan 28
BE - Belgio 27
VE - Venezuela 26
CO - Colombia 24
IN - India 24
AZ - Azerbaigian 22
AT - Austria 19
IR - Iran 19
PL - Polonia 17
KE - Kenya 16
AE - Emirati Arabi Uniti 15
AU - Australia 15
PE - Perù 15
TN - Tunisia 15
UY - Uruguay 15
PY - Paraguay 14
DZ - Algeria 13
KZ - Kazakistan 13
EU - Europa 11
NP - Nepal 10
PA - Panama 10
CH - Svizzera 9
CL - Cile 9
EG - Egitto 9
JO - Giordania 9
RS - Serbia 9
BO - Bolivia 8
AL - Albania 7
HU - Ungheria 7
JP - Giappone 7
LB - Libano 7
PS - Palestinian Territory 7
SN - Senegal 7
IL - Israele 6
OM - Oman 6
BG - Bulgaria 5
BH - Bahrain 5
BY - Bielorussia 5
DO - Repubblica Dominicana 5
GA - Gabon 5
GE - Georgia 5
ID - Indonesia 5
JM - Giamaica 5
KW - Kuwait 5
QA - Qatar 5
BA - Bosnia-Erzegovina 4
HN - Honduras 4
KG - Kirghizistan 4
MD - Moldavia 4
NI - Nicaragua 4
PH - Filippine 4
RO - Romania 4
SA - Arabia Saudita 4
VN - Vietnam 4
AO - Angola 3
CR - Costa Rica 3
GR - Grecia 3
LT - Lituania 3
MK - Macedonia 3
NG - Nigeria 3
SI - Slovenia 3
SK - Slovacchia (Repubblica Slovacca) 3
AM - Armenia 2
BN - Brunei Darussalam 2
CY - Cipro 2
ES - Italia 2
GT - Guatemala 2
HR - Croazia 2
NO - Norvegia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
DK - Danimarca 1
IS - Islanda 1
LU - Lussemburgo 1
Totale 13.313
Salva come PNG Salva come JPEG
Città #
Chandler 913
Singapore 594
Jacksonville 556
Hong Kong 347
Princeton 332
Nanjing 253
Dearborn 187
Rome 131
São Paulo 131
Wilmington 124
Milan 110
Shanghai 108
New York 107
Nanchang 103
Boardman 99
Sassari 98
Ann Arbor 97
Dublin 96
Beijing 74
Shenyang 73
Rio de Janeiro 69
Belo Horizonte 60
Naples 56
Woodbridge 50
Hebei 48
Changsha 45
Tianjin 44
Helsinki 43
Santa Clara 42
Andover 37
Brno 37
Florence 36
Jiaxing 36
Brasília 35
Munich 35
Jinan 34
Porto Alegre 32
Seoul 30
Nuremberg 29
Hangzhou 28
Ningbo 28
Ashburn 27
Brussels 27
Tashkent 27
Campinas 26
Curitiba 25
Zhengzhou 25
Goiânia 24
Norwalk 24
Turin 23
Guarulhos 22
Kunming 22
Toronto 22
Baku 20
Bologna 20
Ribeirão Preto 20
Baghdad 19
Fortaleza 18
Bari 17
Dhaka 17
Juiz de Fora 17
Salvador 17
Campo Grande 16
Sorocaba 16
São Bernardo do Campo 16
Ardabil 15
Montevideo 15
Nairobi 15
San Francisco 15
San Mateo 15
São José dos Campos 15
Leawood 14
Betim 13
Caxias do Sul 13
Guangzhou 13
Joinville 13
Recife 13
Santo André 13
Bogotá 12
Dallas 12
Falkenstein 12
Istanbul 12
Johannesburg 12
Nova Iguaçu 12
Taizhou 12
Verona 12
Volta Redonda 12
Frankfurt am Main 11
Lima 11
Manaus 11
Palermo 11
Aracaju 10
Buenos Aires 10
Contagem 10
Genoa 10
Guayaquil 10
Izmir 10
João Pessoa 10
Mountain View 10
Osasco 10
Totale 6.318
Salva come PNG Salva come JPEG
Nome #
CASE REPORT: MIOCARDITE ACUTA DA CITOMEGALOVIRUS IN GIOVANE PAZIENTE IMMUNOCOMPETENTE 1.490
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 123
Strategie di sorveglianza attiva e networking per il controllo delle infezioni da L. monocytogenes 117
Activation of MSRV-type endogenous retroviruses during infectious mononucleosis and Epstein-Barr virus latency: the missing link with multiple sclerosis? 116
Activation of the potentially neuropathogenic HERV-W/MSRV-type endogenous retroviruses during severe infectious mononucleosis and past Epstein-Barr virus infection: the missing link with multiple sclerosis? 113
Ebola virus disease: Case management in the Institute of Infectious Diseases, University Hospital of Sassari, Sardinia, Italy. 111
Kaposi's sarcoma herpes virus and Kaposi's sarcoma in the elderly populations of 3 Mediterranean islands. 105
Antibiotic resistant H-pylori are extremely common in Sardinia. 104
Accertamento diagnostico di meningoencefalite da Listeria monocytogenes mediante PCR in soggetti immunocompetenti 104
Approccio molecolare nella diagnosi della tubercolosi umana 102
Aspetti epidemiologici sulla colonizzazione da Streptococcus agalactiae nelle donne in gravidanza. 102
Approccio molecolare nello studio di un episodio infettivo ospedaliero da Pseudomonas aeruginosa 99
Genotypic characterization of clarithromycin-resistant Helicobacter pylori strains 97
Utilizzo della metodologia bayesiana per lo studio della variazione geografica del rischio in epidemiologia. 97
Antiretroviral-associated portal hypertension: a new clinical condition? Prevalence, predictors and outcome 97
First HAART in HIV-infected patients with high viral load: value of HIV RNA levels at 12 weeks to predict virologic outcome 95
Mucocutaneous leishmniasis as presentation of HIV infection in Sardinia, insular Italy 94
Valutazione della qualità delle schede di dimissione ospedaliera 94
Analisi dell'attività dei C.I.O. in ambito regionale e proposta di un modello organizzativo - funzionale 93
HCV NS3 sequencing as a reliable and clinically useful tool for the assessment of genotype and resistance mutations for clinical samples with different HCV-RNA levels. 92
Aspetti epidemiologici di infezioni gastroenteriche in paesi in via di sviluppo 91
Analisi del case-mix ospedaliero. Il controllo dei ricoveri outlier 89
Incidence of neutropenia and infections during combination treatment of chronic hepatitis C with pegylated interferon alfa-2a or alfa-2b plus ribavirin 89
OPERA: use of pegylated interferon plus ribavirin for treating hepatitis C/HIV co-infection in interferon-naive patients. 88
Listeria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 87
Does Angiotensin II receptor blockers increase the risk of SARS-CoV-2 infection? A real-life experience 87
Associazione sierologia tra HIV e Trichomonas vaginalis nella popolazione femminile del Nord-Sardegna. 87
alpha-and gamma-tocophetol modulate the apoptotic signaling induced by oxidized low-density lipoprotein in human coronaric smooth muscle cells 87
HIV related aneurisms 86
Hepatotoxicity of Antiretroviral Drugs Is Reduced after Successful Treatment of Chronic Hepatitis C in HIV-Infected Patients 85
Higher Risk of Hyperglycemia in HIV-Infected Patients Treated with Didanosine Plus Tenofovir 84
Clonal relationships among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 84
QuantiFERON TB Gold: a new method for latent tuberculosis infection 84
Andamento della parotite epidemica nell’Azienda USL n.1 di Sassari e considerazioni sulle strategie vaccinali 83
Profile of patients triply infected with HIV and the hepatitis B and C viruses in the HAART era 83
Predictors of Hepatitis C Treatment Failure After Using Direct-Acting Antivirals in People Living With Human Immunodeficiency Virus 83
Predictors of Virological Response to Atazanavir in Protease Inhibitor-Experienced Patients 82
Andamento delle infezioni nosocomiali nel complesso chirurgico Università- Azienda USL n. 1- Sassari. 82
Dalbavancin two dose regimen for the treatment of prosthetic joint infections: new possible options for difficult to treat infectious diseases 82
Triple combination therapy for hepatitis C with telaprevir exhibits greater early antiviral activity than with boceprevir. 82
Cytopenias during treatment of HIV-HCV-coinfection with pegylated interferon and ribavirin: safety analysis of the OPERA study. 81
Caratteristiche cliniche e risposta alla terapia anti-HCV nei soggetti HIV-HCV coinfetti con livelli persistentemente normali di ALT 81
Monitoraggio di metalli pesanti nelle acque costiere della Sardegna settentrionale mediante utilizzo di indicatori biologici 81
Autoimmune hepatitis induced by pegylated interferon in an HIV-infected patient with chronic hepatitis C 81
Differences in liver fibrosis and response to pegylated interferon plus ribavirin in HIV/HCV-coinfected patients with normal vs elevated liver enzymes 80
Visceral Leishmaniasis and Pegylated Interferon. Author’s reply 79
Characteristics and Prospects for Hepatitis C Therapy of an HIV-HCV Coinfected Population Followed at a Reference HIV Center 79
Multiclass HCV resistance to interferon-free direct acting antivirals regimens in real life failures advocates for tailored second-line therapies 79
PREVENTION OF TRAVEL ASSOCIATED INFECTION DUE TO LEGIONELLA: MICROBIOLOGIC ANALYSIS IN LINERS AND CRUISE SHIPS 78
DNMT1 modulation in chronic hepatitis B patients and hypothetic influence on mitochondrial DNA methylation status during long-term nucleo(t)side analogs therapy 78
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 78
Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma 77
Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience 77
Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection. 77
Serum homocysteine levels are increased in women with gestational diabetes mellitus 76
Inquinamento ambientale nelle sale operatorie. Nota II: condizioni microclimatiche e microbiologiche 76
Long-term follow-up of HIV-infected patients with chronic hepatitis C virus infection treated with interferon-based therapies 74
Rapid detection and identification of Mycobacterium tuberculosis by Real Time PCR and Bactec 960 MIGT 74
Surveillance of Poliomyelitis in Italy: immunity status of population against polio and environmental circulation of Poliovirus. General illustration of the results 74
Episodes of low-level viral rebound in HIV-infected patients on antiretroviral therapy: frequency, predictors and outcome 73
Database per il monitoraggio del rischio professionale negli operatori sanitari 73
Database per il monitoraggio del rischio professionale negli operatori sanitari 72
Modulation by α- and γ-tochopherol and oxidized low density lipoprotein in human coronaric smooth muscle cells 72
Triple-nucleoside regimens versus efavirenz 71
Safety and efficacy of direct-acting antivirals in transfusion-dependent thalassemic patients with chronic hepatitis C 71
Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy 71
Hepatitis C virus-RNAclearance in HIV-coinfected patients with chronic hepatitis C treated with pegylated interferon plus ribavirin 71
Early treatment with low-molecular-weight heparin reduces mortality rate in SARS-CoV-2 patients 71
Lysteria monocytogenes meningoencephalitis: molecular methods for diagnosis and for monitoring the response to chemotherapy 70
Very late HCV relapse following triple therapy for hepatitis C. 69
Use of pegylated interferons is associated with an increased incidence of infections during combination treatment of chronic hepatitis C: a side effect of pegylation? 69
Does counselling increase sustained benefit of HAART among prison inmates after release to the community? 69
New paradigms in the management of HIV and hepatitis C virus coinfection 69
Simplification From Protease Inhibitors to Once- or Twice-Daily Raltegravir: The ODIS Trial 69
Effectiveness of Vitamin D Supplements among Patients Hospitalized for COVID-19: Results from a Monocentric Matched-Cohort Study 69
Clonal relations among Salmonella enteritidis phage type 3 outbreak isolates traced by DNA fingerprinting 68
Severe portal hypertension not associated to cirrhosis in HIV+ patients 68
Severe portal hypertension in HIV patients with no primary liver disease: prevalence, histology and potential etiology 68
Upper Gastrointestinal Bleeding May Unmask Didanosine-Associated Portal Hepatopathy in HIV/HCV Co-infected Patients 67
Hepatitis C Viremia in HIV/HCV-Coinfected Patients: Lower Levels in Presence of Chronic Hepatitis B 67
EFFECTIVENESS OF SOFOSBUVIR/VELPATASVIR (SOF/VEL) IN PATIENTS WITH CHRONIC HCV INFECTION AND PSYCHIATRIC DISORDERS: REAL-WORLD CARE MANAGEMENT FROM 6 COUNTRIES 67
Distinct hepatitis C virus kinetics in HIV-infected patients treated with ribavirin plus either pegylated interferon alpha2a or alpha2b 67
HCV treatment in Sardinian HIV-HCV coinfected patients: a real-life perspective study on safety, efficacy, and immune reconstitution 67
Liver Fibrosis Stage and HCV Genotype Distribution in HIV-HCV Coinfected Patients with Persistently Normal Transaminases 66
Comparison of 2D Shear Wave Elastography and Transient Elastography in Non-Invasive Evaluation of Liver Fibrosis in Hepatitis C Virus-Related Chronic Liver Disease 65
Predictability of sustained virological response to pegylated interferon alpha-2b Plus ribavirin therapy by week-8 viral response in HIV-positive patients with chronic hepatitis C virus infection 65
Hepatic peroxisome proliferator-activated receptor γ and α-mRNA expression in HCV-infected adults is decreased by HIV co-infection and is also affected by ethnicity 65
Occurrence of infections during combination treatment with interferons and ribavirin for chronic hepatitis C: Role of neutropenia and of interferon pegylation 65
Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens? 64
Epidemiology of Salmonellosis in Sardinia, Italy: 1995-2001 64
HIV associated hepatopathy – a new clinical condition: prevalence, etiology and outcome 64
Characterization of resistance profiles in HCV 2-3-4 DAA-naive and DAA-experienced infected patients in Italy 63
Correlates of HIV, HBV, and HCV infection in a prison inmate population: Results from a multicentre study in Italy 63
Joint replacement for avascular necrosis in people living with HIV 63
Unexplained severe portal hypertension in HIV-infected patients: a new clinical entity? 62
Profilo di efficacia e sicurezza di boceprevir e telaprevir in pazienti HCV positivi 62
The changing face of the HIV epidemic in Northern Sardinia: increased diagnoses among pregnant women 62
HIV-HCV co-infection: epidemiology, pathogenesis and therapeutic implications. 62
Complications in treating chronic hepatitis B in patients with HIV 62
Impact of the presence of the infectious disease specialist in addiction services (SerDs) as a point-of-care to meet WHO goal of HCV eradication 62
Totale 9.377
Salva come PNG Salva come JPEG
Categoria #
all - tutte 59.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 59.108
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020318 0 0 0 0 0 0 0 0 0 141 163 14
2020/20211.485 165 9 212 15 155 82 164 16 244 230 138 55
2021/2022965 152 27 24 46 18 19 45 67 77 32 110 348
2022/20231.962 199 101 39 314 190 334 21 222 331 25 108 78
2023/2024930 105 62 32 41 193 96 27 52 16 57 97 152
2024/20255.197 113 161 376 137 199 197 365 1.084 1.975 590 0 0
Totale 13.641